| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michelle R Ciucci, Allison M Ahrens, Sean T Ma, Jacqueline R Kane, E Blake Windham, Martin T Woodlee, Timothy Schaller. Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats. Behavioral neuroscience. vol 123. issue 2. 2009-05-18. PMID:19331456. |
although vocalization in animals and humans may differ in many respects, we evaluated complex (50-khz) ultrasonic mate calls in 2 rat models of parkinson's disease, including unilateral infusions of 6-hydroxydopamine to the medial forebrain bundle and peripheral administration of a nonakinesia dose of the dopamine antagonist haloperidol. |
2009-05-18 |
2023-08-12 |
rat |
| Carmela Dell'aversano, Carmine Tomasetti, Felice Iasevoli, Andrea de Bartolomei. Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders. Brain research bulletin. vol 79. issue 2. 2009-04-28. PMID:19189858. |
oppositely, in the cortex the two transcripts are modulated by both haloperidol and ssris, suggesting a possible role of both dopamine and serotonin in their cortical regulation. |
2009-04-28 |
2023-08-12 |
Not clear |
| Tsung-Tsair Yang, Su-Jane Wan. Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia. Synapse (New York, N.Y.). vol 62. issue 11. 2009-04-21. PMID:18720421. |
in addition, the dopamine d2 receptor antagonist haloperidol and the 5-ht 1a receptor antagonist way100635 all effectively blocked the aripiprazole or opc13857-mediated inhibition of 4-ap-evoked glutamate release. |
2009-04-21 |
2023-08-12 |
human |
| Mahendra Bishnoi, Kanwaljit Chopra, Shrinivas K Kulkarn. Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels. Pharmacology, biochemistry, and behavior. vol 91. issue 3. 2009-04-02. PMID:18789960. |
on chronic administration of haloperidol, there was a decrease in the striatal levels of dopamine, which was again reversed by treatment with no donors. |
2009-04-02 |
2023-08-12 |
rat |
| Katsutoshi Shioda, Koichi Nisijima, Tatsuki Yoshino, Kyoko Kuboshima, Tatsunori Iwamura, Kunio Yui, Satoshi Kat. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats. Neurotoxicology. vol 29. issue 6. 2009-03-26. PMID:18722468. |
pretreatment with haloperidol, which blocks the dopamine (da) receptors d(2) and d(1), significantly prevented mdma-induced hyperthermia. |
2009-03-26 |
2023-08-12 |
rat |
| Béla Kiss, István Laszlovszky, Attila Horváth, Zsolt Némethy, Eva Schmidt, Gyula Bugovics, Károly Fazekas, István Gyertyán, Eva Agai-Csongor, György Domány, Zsolt Szombathely. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15. Naunyn-Schmiedeberg's archives of pharmacology. vol 378. issue 5. 2009-03-23. PMID:18551280. |
rg-15, similar to haloperidol and amisulpride, dose-dependently inhibited in vivo [3h]raclopride binding in mouse striatum, enhanced dopamine turnover and synthesis rate in mouse and rat striatum and olfactory tubercle. |
2009-03-23 |
2023-08-12 |
mouse |
| Béla Kiss, István Laszlovszky, Attila Horváth, Zsolt Némethy, Eva Schmidt, Gyula Bugovics, Károly Fazekas, István Gyertyán, Eva Agai-Csongor, György Domány, Zsolt Szombathely. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15. Naunyn-Schmiedeberg's archives of pharmacology. vol 378. issue 5. 2009-03-23. PMID:18551280. |
rg-15 and haloperidol, but not sb-277011, antagonised dopamine synthesis inhibition induced by the d3/d2 full agonist 7-oh-dpat in gbl-treated mice. |
2009-03-23 |
2023-08-12 |
mouse |
| Steven J Shoptaw, Uyen Kao, Walter Lin. Treatment for amphetamine psychosis. The Cochrane database of systematic reviews. issue 1. 2009-03-19. PMID:19160215. |
it has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis. |
2009-03-19 |
2023-08-12 |
Not clear |
| Joseph H Porter, David Matthew Walentiny, Scott D Philibin, Sarah A Vunck, John C Crabb. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice. Behavioural pharmacology. vol 19. issue 5-6. 2008-12-31. PMID:18690107. |
the typical antipsychotic drug haloperidol produced partial substitution for clz in the dba/2 mice, and the dopamine agonist amphetamine required a higher dose to reduce response rates significantly in dba/2 mice as compared with c57bl/6 mice. |
2008-12-31 |
2023-08-12 |
mouse |
| Andrea Gogos, Mirjana Bogeski, Maarten van den Buus. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behavioural pharmacology. vol 19. issue 5-6. 2008-12-31. PMID:18690109. |
in balb/c mice, the effect of 8-oh-dpat was blocked by the typical antipsychotic and dopamine d2 receptor antagonist, haloperidol and the third generation antipsychotic, aripiprazole, which has activity at both 5-ht1a and dopamine d2 receptors. |
2008-12-31 |
2023-08-12 |
mouse |
| Mahendra Bishnoi, Kanwaljit Chopra, Shrinivas K Kulkarn. Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study. Neurochemical research. vol 33. issue 9. 2008-10-31. PMID:18363098. |
neurochemically, chronic administration of haloperidol resulted in significant decrease in levels of catecholamines (dopamine, serotonin) and their metabolites (hva and hiaa) but increased turnover of dopamine and serotonin. |
2008-10-31 |
2023-08-12 |
rat |
| Marie-Bernadette Assié, Elisabeth Carilla-Durand, Laurent Bardin, Mireille Maraval, Monique Aliaga, Nathalie Malfètes, Michèle Barbara, Adrian Newman-Tancred. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. European journal of pharmacology. vol 592. issue 1-3. 2008-10-24. PMID:18640111. |
here, we compared the influence on plasma glucose and corticosterone of acute treatments with 'new generation' antipsychotics which target dopamine d2/3 receptors and 5-ht1a receptors, with that of atypical antipsychotics, and with haloperidol. |
2008-10-24 |
2023-08-12 |
rat |
| Mahendra Bishnoi, Kanwaljit Chopra, Shrinivas K Kulkarn. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 6. 2008-10-22. PMID:18554768. |
differential effect of haloperidol and atypical neuroleptics on striatal dopamine levels and striatal levels of tnf-alpha and nfkappab p65 subunit was found out. |
2008-10-22 |
2023-08-12 |
human |
| Mahendra Bishnoi, Kanwaljit Chopra, Shrinivas K Kulkarn. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 6. 2008-10-22. PMID:18554768. |
haloperidol significantly decreased the striatal dopamine levels whereas clozapine and risperidone did not. |
2008-10-22 |
2023-08-12 |
human |
| Lisa Loh. Chemotherapy-induced nausea and vomiting. Cancer journal (Sudbury, Mass.). vol 14. issue 2. 2008-09-04. PMID:18391612. |
medications for breakthrough symptoms include dopamine antagonists, lorazepam, metoclopramide, haloperidol, droperidol and other agents. |
2008-09-04 |
2023-08-12 |
Not clear |
| Ib V Klewe, Søren M Nielsen, Louise Tarpø, Eneko Urizar, Concetta Dipace, Jonathan A Javitch, Ulrik Gether, Jan Egebjerg, Kenneth V Christense. Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling. Neuropharmacology. vol 54. issue 8. 2008-08-25. PMID:18455202. |
moreover, we observed that haloperidol, sertindole, olanzapine, clozapine and ziprasidone all fully inhibited the dopamine induced beta-arrestin2 recruitment to d2 receptor (short variant) in a concentration dependent manner. |
2008-08-25 |
2023-08-12 |
human |
| Mervan S Agovic, Elena Yablonsky-Alter, Theodore I Lidsky, Shailesh P Banerje. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats. European journal of pharmacology. vol 587. issue 1-3. 2008-08-25. PMID:18457824. |
typical antipsychotics such as the dopamine d(2) receptor antagonist, haloperidol are known to cause movement disorders or catalepsy in experimental animals. |
2008-08-25 |
2023-08-12 |
rat |
| Mervan S Agovic, Elena Yablonsky-Alter, Theodore I Lidsky, Shailesh P Banerje. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats. European journal of pharmacology. vol 587. issue 1-3. 2008-08-25. PMID:18457824. |
haloperidol, another potent dopamine d(2) receptor blocker at 0.5 mg/kg (s.c.) rapidly produced catalepsy and suppressed movement 1 h after a single dose of the drug. |
2008-08-25 |
2023-08-12 |
rat |
| Mervan S Agovic, Elena Yablonsky-Alter, Theodore I Lidsky, Shailesh P Banerje. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats. European journal of pharmacology. vol 587. issue 1-3. 2008-08-25. PMID:18457824. |
however, no changes in dopamine d(2) receptor numbers were noted in these areas after chronic treatment with low doses of haloperidol. |
2008-08-25 |
2023-08-12 |
rat |
| Hui-Dong Wang, Ariel Y Deutc. Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 6. 2008-08-07. PMID:17687264. |
we then examined rats in which the pfc dopamine innervation was lesioned and 3 weeks later were started on chronic treatment with an atypical (olanzapine) or typical (haloperidol) antipsychotic drug. |
2008-08-07 |
2023-08-12 |
rat |